(PIPR) Piper Sandler Companies - Overview
Stock: Investment Banking, Advisory, Trading, Research, Asset Management
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.07% |
| Yield on Cost 5y | 6.39% |
| Yield CAGR 5y | -4.32% |
| Payout Consistency | 89.3% |
| Payout Ratio | 52.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 37.5% |
| Relative Tail Risk | -6.38% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.48 |
| Alpha | -6.39 |
| Character TTM | |
|---|---|
| Beta | 1.482 |
| Beta Downside | 1.376 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.78% |
| CAGR/Max DD | 0.92 |
Description: PIPR Piper Sandler Companies January 09, 2026
Piper Sandler Companies (NYSE:PIPR) is a full-service investment bank and institutional securities firm that advises corporations, private-equity sponsors, public entities, non-profits and institutional investors across the U.S. and abroad. Its core offerings include investment-banking (M&A, equity and debt financings, private placements, restructuring), institutional sales and trading of equities and fixed-income, research, and municipal finance services such as loan placement and underwriting of local-government issuances.
Beyond traditional banking, the firm runs alternative-asset-management platforms focused on merchant-banking and healthcare, deploying both firm-capital and third-party capital. In FY 2023 the company reported roughly $2.2 billion in total revenue, with investment-banking fees contributing about 45 % and municipal finance accounting for another 20 %-a mix that buffers earnings against cyclical swings in corporate M&A activity.
Key economic drivers for Piper Sandler include the pace of U.S. M&A (which rose ~12 % YoY in Q4 2023), municipal-bond issuance trends tied to state-level infrastructure spending, and interest-rate volatility that fuels demand for fixed-income trading and derivative hedging. The firm’s deep relationships in education, healthcare, and senior-living sectors also position it to capture financing flows as demographic trends spur capital needs in those markets.
For a deeper quantitative view, you might explore ValueRay’s analyst dashboard on PIPR’s valuation metrics.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 236.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -28.59 > 1.0 |
| NWC/Revenue: 36.47% < 20% (prev 32.63%; Δ 3.84% < -1%) |
| CFO/TA 0.01 > 3% & CFO 20.7m > Net Income 236.4m |
| Net Debt (660.0k) to EBITDA (294.4m): 0.00 < 3 |
| Current Ratio: 6.99 > 1.5 & < 3 |
| Outstanding Shares: last quarter (17.8m) vs 12m ago 0.22% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 78.65% > 50% (prev 72.83%; Δ 5.82% > 0%) |
| Interest Coverage Ratio: 51.76 > 6 (EBITDA TTM 294.4m / Interest Expense TTM 5.18m) |
Altman Z'' 4.45
| A: 0.27 (Total Current Assets 711.6m - Total Current Liabilities 101.8m) / Total Assets 2.22b |
| B: 0.28 (Retained Earnings 629.8m / Total Assets 2.22b) |
| C: 0.13 (EBIT TTM 267.9m / Avg Total Assets 2.13b) |
| D: 0.84 (Book Value of Equity 632.4m / Total Liabilities 756.7m) |
| Altman-Z'' Score: 4.45 = AA |
Beneish M -1.27
| DSRI: 2.96 (Receivables 576.6m/172.3m, Revenue 1.67b/1.48b) |
| GMI: 1.00 (GM 99.69% / 99.54%) |
| AQI: 0.92 (AQ_t 0.61 / AQ_t-1 0.67) |
| SGI: 1.13 (Revenue 1.67b / 1.48b) |
| TATA: 0.10 (NI 236.4m - CFO 20.7m) / TA 2.22b) |
| Beneish M-Score: -1.27 (Cap -4..+1) = D |
What is the price of PIPR shares?
Over the past week, the price has changed by +5.21%, over one month by -0.89%, over three months by +11.12% and over the past year by +16.37%.
Is PIPR a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PIPR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 410.7 | 12.7% |
| Analysts Target Price | 410.7 | 12.7% |
| ValueRay Target Price | 472.7 | 29.7% |
PIPR Fundamental Data Overview February 07, 2026
P/S = 3.2124
P/B = 4.4672
Revenue TTM = 1.67b USD
EBIT TTM = 267.9m USD
EBITDA TTM = 294.4m USD
Long Term Debt = 99.7m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 15.0m USD (from shortTermDebt, last quarter)
Debt = 114.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 660.0k USD (from netDebt column, last quarter)
Enterprise Value = 5.52b USD (5.52b + Debt 114.7m - CCE 114.0m)
Interest Coverage Ratio = 51.76 (Ebit TTM 267.9m / Interest Expense TTM 5.18m)
EV/FCF = -289.6x (Enterprise Value 5.52b / FCF TTM -19.1m)
FCF Yield = -0.35% (FCF TTM -19.1m / Enterprise Value 5.52b)
FCF Margin = -1.14% (FCF TTM -19.1m / Revenue TTM 1.67b)
Net Margin = 14.14% (Net Income TTM 236.4m / Revenue TTM 1.67b)
Gross Margin = unknown ((Revenue TTM 1.67b - Cost of Revenue TTM 5.18m) / Revenue TTM)
Tobins Q-Ratio = 2.49 (Enterprise Value 5.52b / Total Assets 2.22b)
Interest Expense / Debt = 0.71% (Interest Expense 818.0k / Debt 114.7m)
Taxrate = 23.22% (24.9m / 107.4m)
NOPAT = 205.7m (EBIT 267.9m * (1 - 23.22%))
Current Ratio = 6.99 (Total Current Assets 711.6m / Total Current Liabilities 101.8m)
Debt / Equity = 0.09 (Debt 114.7m / totalStockholderEquity, last quarter 1.28b)
Debt / EBITDA = 0.00 (Net Debt 660.0k / EBITDA 294.4m)
Debt / FCF = -0.03 (negative FCF - burning cash) (Net Debt 660.0k / FCF TTM -19.1m)
Total Stockholder Equity = 1.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.12% (Net Income 236.4m / Total Assets 2.22b)
RoE = 19.09% (Net Income TTM 236.4m / Total Stockholder Equity 1.24b)
RoCE = 20.02% (EBIT 267.9m / Capital Employed (Equity 1.24b + L.T.Debt 99.7m))
RoIC = 16.43% (NOPAT 205.7m / Invested Capital 1.25b)
WACC = 11.16% (E(5.52b)/V(5.63b) * Re(11.38%) + D(114.7m)/V(5.63b) * Rd(0.71%) * (1-Tc(0.23)))
Discount Rate = 11.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.26%
Fair Price DCF = unknown (Cash Flow -19.1m)
EPS Correlation: -12.00 | EPS CAGR: -49.16% | SUE: -4.0 | # QB: 0
Revenue Correlation: 6.85 | Revenue CAGR: -8.13% | SUE: 1.20 | # QB: 2
EPS next Quarter (2026-03-31): EPS=3.97 | Chg30d=-0.063 | Revisions Net=+1 | Analysts=5
EPS next Year (2026-12-31): EPS=18.21 | Chg30d=-0.387 | Revisions Net=+1 | Growth EPS=+17.0% | Growth Revenue=+14.8%